Tribromoisocyanuric Acid (TBCA) and Oxone®‐MX Systems as Oxidizing Agents: Oxidative Coupling of Thiols to Their Corresponding Disulfides under Mild and Heterogeneous Conditions

Tribromoisocyanuric acid (TBCA) and Oxone^®‐MX systems were used as effective oxidizing agents for the oxidation of thiols to their corresponding disulfides under mild conditions at room temperature with good to excellent yields.     

Mizoroki–Heck and Suzuki–Miyaura reactions mediated by poly(2‐acrylamido‐2‐methyl‐1‐propanesulfonic acid)‐stabilized magnetically separable palladium catalyst

The purpose of this work was to synthesize and characterize a new magnetic polymer nanosphere‐supported palladium(II) acetate catalyst for reactions requiring harsh conditions. In this regard, an air‐stable, moisture‐stable and highly efficient heterogenized palladium was synthesized by the coordination of palladium(II) acetate with poly(2‐acrylamido‐2‐methyl‐1‐propanesulfonic acid)‐grafted modified magnetic nanoparticles with a core–shell structure. The structure of the newly developed catalyst was characterized using various techniques. The catalytic activity of the resultant nano‐organometallic catalyst was evaluated in Mizoroki–Heck and Suzuki–Miyaura reactions to afford the corresponding coupling products in good to excellent yields. High selectivity as well as outstanding turnover number (14 143, 4900) and turnover frequency (28 296, 7424) values were recorded for the catalyst in Suzuki–Miyaura and Mizoroki–Heck reactions, respectively. Magnetic separation and recycling of the catalyst for at least six runs became possible without any significant loss of efficiency or any detectable palladium leaching.     

Three-component solvent-free synthesis of 5-substituted-1H-tetrazoles catalyzed by unmodified nanomagnetite with microwave irradiation or conventional heating

Research on Chemical Intermediates - A convenient, rapid, and highly efficient procedure for synthesis of 5-substituted-1H-tetrazoles was developed via multicomponent domino Knoevenagel...     

2-（1,3-Diphenylpropen-1,3-diolato）-1,3,2-（5-formylbenzo）dioxaborol： A ＇Whole-molecule Disorder＇ Crystal Structure

The boron atom in C22H15BO5 is O,O’-chelated by the anions in a tetrahedral geometry, with the planar five-and six-membered chelate rings being orthogonal to each other. The molecule lies on a two-fold rotation axis. The molecule is disordered with respect to another molecule in a 93:7 ratio; the treatment of the ‘whole-molecule disorder’ by employing a large number of restraints is described. Crystal data: C22H15BO5, monoclinic C2/c, a = 17.1804(5), b = 12.9409(4), c = 9.8842(3) , β = 124.832(2)o, V = 1803.82(9) 3 at –173 K.     

Organocatalytic synthesis of amides from nitriles via the Ritter reaction

A simple, inexpensive, environmentally friendly, and efficient route for the synthesis of a wide variety of amides in high yields via the Ritter reaction of alcohols with nitriles has been demonstrated. Pentafluorophenyl ammonium triflate (PFPAT) is used as an organocatalyst and is air-stable, cost-effective, easy to handle, and easily removed from the reaction mixtures.     

Nonlinear Filtering in Rieznnnnifln Manifolds

A general formulation of the nonlinear filtering problem inRiemanman manifolds is given by use of the strong solutionsof the stochastic differential equations for the state and observationprocesses in the orthonormal frame bundles of the state andobservation process manifolds, respectively. A general Bayesformula for the conditional expectation of smooth functionsof the state process is given. This is used to give a directderivation of the Zakai equation for the general problem underconsideration. An example is presented.     

Factorization of proper holomorphic maps on irreducible bounded symmetric domains of rank≥2

We obtain rigidity results on arbitrary proper holomorphic maps F from an irreducible bounded symmetric domain Ω of rank ≥2 into any complex space Z. After lifting to the normalization of the subvariety F (Ω) Z, we prove that F must be the canonical projection map to the quotient space of Ω by a finite group of automorphisms. The approach is along the line of the works of Mok and Tsai by considering radial limits of bounded holomorphic functions derived from F and proving that proper holomorphic maps between bounded symmetric domains preserve certain totally geodesic subdomains. In contrast to the previous works, in general we have to deal with multivalent holomorphic maps for which Fatou’s theorem cannot be applied directly. We bypass the difficulty by devising a limiting process for taking radial limits of correspondences arising from proper holomorphic maps and by elementary estimates allowing us to define distinct univalent branches of the underlying multivalent map on certain subsets. As a consequence of our rigidity result, with the exception of Type-IV domains, any proper holomorphic map f : Ω→ D of Ω onto a bounded convex domain D is necessarily a biholomorphism. In the exceptional case where Ω is a Type-IV domain, either f is a biholomorphism or it is a double cover branched over a totally geodesic submanifold which can be explicitly described.     

Synthesis of Novel 3-(5-(Alkyl/arylthio)-1,3,4-Oxadiazol-2-yl)-8-Phenylquinolin-4(1H)-One Derivatives as Anti-HIV Agents

Novel quinolone derivatives featuring an 1,3,4-oxadiazole ring as a metal-chelating component and a benzyl group base on HIV-1 integrase inhibitors pharmacophore were designed and synthesized. An antiviral assay revealed that most analogues inhibited HIV-1 replication in the cell culture. Our results showed that compounds bearing small alkyl groups as R group were inactive in anti-HIV-1 assay, whereas compounds possessing benzyl or substituted benzyl at the same position showed good anti-HIV activity with the range of 20–57% at 100 μM concentration. Among them, 3-(5-((2-fluorobenzyl)thio)-1,3,4-oxadiazol-2-yl)-8-phenylquinolin-4-(1H)-one (compound 13) showed reasonable cell-based antiviral activity (EC₅₀ = 50 μM) with no considerable cytotoxicity (CC₅₀ > 100 μM) in the cell viability assay, suggesting that it may be amenable to further development for identifying new anti-HIV-1 agents. Docking studies using the later crystallographic data available for PFV integrase corroborate favorable binding to the active site of HIV integrase, providing a basis for the design of more potent analogues.